Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: salt mines in Pakistan
DNA G+C(%): 39.1
|
Opt. T: 30-35℃
Low T(℃): 10(+)
Mid T(℃): 40(+)
NaCl 0.5-2%: 0(+)
NaCl >6%: 17(+)
Opt. pH: 8.0
pH 4.2-5.9: 5(+)
pH >8: 9(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: S(4)
Augmentin: S(2/4)
oxacillin: S(2)
penicillin: R(0.25)
|
cefoperazone: S(4)
cephalothin: S(8)
|
apramycin: Var(MIC50): 16), MIC90: Var(16
gentamicin: S(4)
kanamycin: S(8)
spectinomycin: S(64)
streptomycin: S(8)
|
erythromycin: R(1)
pristinamycin: R(2)
|
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(4)
tetracycline: S(4)
|
|
rifampicin: S(4)
|
chloramphenicol: R(8)
metronidazole: R(4)
nitrofurantoin: Var(MIC50): 25), MIC90: Var(25
co-trimoxazole: Var(MIC50): 2, MIC90: 38
|
lincomycin: R(2)
colistin: S(4)
fusidic-acid: R(2)
|